Brief: Bellerophon Reports Positive Top-Line Data From An Ancillary Acute Hemodynamic Study Of Inopulse

Bellerophon Therapeutics

18/02/2020 14:21

Feb 18 (Reuters) - Bellerophon Therapeutics Inc  BLPH.O :
    * BELLEROPHON REPORTS POSITIVE TOP-LINE DATA FROM AN
ANCILLARY
ACUTE HEMODYNAMIC STUDY OF INOPULSE® FOR TREATMENT OF PULMONARY
HYPERTENSION ASSOCIATED WITH PULMONARY FIBROSIS
    * BELLEROPHON -  RESULTS SHOWED THAT ACUTE TREATMENT WITH
INOPULSE
PROVIDED STATISTICALLY, CLINICALLY SIGNIFICANT IMPROVEMENTS IN
HEMODYNAMIC PARAMETERS
    * BELLEROPHON THERAPEUTICS INC - INO WAS WELL-TOLERATED WITH
NO
SAFETY CONCERNS ACROSS DOSES
    * BELLEROPHON THERAPEUTICS INC - FINDINGS ARE CONSISTENT
WITH
COMPELLING RESULTS FROM PHASE 2 OF OUR INO-PF CHRONIC STUDY

Source text for Eikon:  ID:nGNXD4WN2 
Further company coverage:  BLPH.O 

 (Reuters.Briefs@thomsonreuters.com)